TPICAP Midcap initiated coverage of MedinCell’s stock with a study entitled “Pipeline maturation: 1st launch likely in H1-23“, giving a recommendation to buy the stock with a price target of 15 euros per share.
Contacts
MedinCell announces the initiation of coverage of its stock by TPICAP Midcap
January 5, 2023